MDXG FY 2022 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$268M+10.7% YoY

Gross Profit

$220M82.0% margin

Operating Income

-$15M-5.5% margin

Net Income

-$30M-11.3% margin

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$171M

Total Liabilities

$97M

Stockholders' Equity

$75M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$268M	$242M	+10.7%
Gross Profit	$220M	$202M	+8.5%
Operating Income	-$15M	-$7M	-108.9%
Net Income	-$30M	-$12M	-145.5%